系统性皮质类固醇使用在亚洲喘管理中的负担
Raja Dhar1, Chin Kook Rhee2, Diahn-Warng Perng3
1Department of Pulmonology, CK Birla Group of Hospitals, Kolkata, West Bengal, India.
系统性皮质类固醇 (SCS) 在亚洲的严重喘管理中被过度使用,尽管存在严重健康问题的风险. 减少这种过度使用需要在多个层面上协调努力,以改善患者的治疗结果.
科学领域:
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
背景情况:
- 喘管理通常依赖于吸入药物.
- 严重或不受控制的喘可能需要全身皮质类固醇 (SCSs).
- 长期的SCS暴露带来风险,包括糖尿病,功能障碍,心血管疾病和死亡率.
研究的目的:
- 调查亚洲喘管理中过度使用SCS的情况.
- 突出相关的医疗负担和不良健康结果.
- 提出减少SCS过度使用的战略.
主要方法:
- 全球和亚洲对喘严重程度,控制和治疗实践的临床和现实数据的审查.
- 分析亚洲国家关于SCS使用模式的现有数据.
- 综合导致SCS过度使用的因素.
主要成果:
- 全球数据表明,SCS在喘管理中的过度使用.
- 现有的亚洲数据表明,尽管各国之间存在差异,但SCS过度使用的模式类似.
- 过度使用SCS对喘患者的医疗负担作出了重大贡献.
结论:
- 系统性皮质类固醇的过度使用是亚洲喘护理的一个重要问题.
- 需要协调干预,涉及患者,提供者,机构和政策制定者.
- 策略包括提高疾病意识,遵守指南,并促进SCSs的替代品.
更多相关视频
04:03Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
Published on: September 27, 2024
07:28Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
相关概念视频
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
COPD: Management Using Bronchodilators and Corticosteroids
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma-IV: Nursing Management
First, in...
